Adam Maeder
Stock Analyst at Piper Sandler
(4.75)
# 808
Out of 5,090 analysts
354
Total ratings
56.5%
Success rate
13.8%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Reiterated: Hold | $225 → $260 | $229.94 | +13.07% | 9 | Oct 30, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $195 → $240 | $237.60 | +1.01% | 21 | Oct 29, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $118 | $106.20 | +11.11% | 21 | Oct 22, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $470 | $432.01 | +8.79% | 54 | Oct 21, 2026 | |
| IRTC iRhythm Holdings | Initiated Coverage: Buy | $160 | $123.37 | +29.69% | 1 | Oct 16, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Buy | $25 | $19.20 | +30.21% | 1 | Oct 16, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $60 | $68.10 | -11.89% | 51 | Oct 2, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $101 | $92.01 | +9.77% | 57 | Sep 21, 2026 | |
| LIVN LivaNova | Reiterated: Buy | $87 → $90 | $78.97 | +13.97% | 34 | Sep 2, 2026 | |
| STAA STAAR Surgical Company | Reiterated: Hold | $33 | $24.54 | +34.47% | 7 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $4.87 | +105.34% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $9.32 | -3.43% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.45 | +566.67% | 8 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $0.8626 | +305.75% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $23.04 | +82.29% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $3 | $2.25 | +33.33% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.5 → $7 | $0.00845 | n/a | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $48.68 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.50 → $2.10 | $0.11 | n/a | 2 | Dec 23, 2019 |
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: $225 → $260
Current: $229.94
Upside: +13.07%
Glaukos
Oct 29, 2026
Reiterated: Buy
Price Target: $195 → $240
Current: $237.60
Upside: +1.01%
Abbott Laboratories
Oct 22, 2026
Reiterated: Buy
Price Target: $118
Current: $106.20
Upside: +11.11%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $470
Current: $432.01
Upside: +8.79%
iRhythm Holdings
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $123.37
Upside: +29.69%
PROCEPT BioRobotics
Oct 16, 2026
Reiterated: Buy
Price Target: $25
Current: $19.20
Upside: +30.21%
Inspire Medical Systems
Oct 2, 2026
Reiterated: Hold
Price Target: $60
Current: $68.10
Upside: -11.89%
Edwards Lifesciences
Sep 21, 2026
Reiterated: Buy
Price Target: $101
Current: $92.01
Upside: +9.77%
LivaNova
Sep 2, 2026
Reiterated: Buy
Price Target: $87 → $90
Current: $78.97
Upside: +13.97%
STAAR Surgical Company
Aug 13, 2026
Reiterated: Hold
Price Target: $33
Current: $24.54
Upside: +34.47%
Aug 6, 2026
Reiterated: Hold
Price Target: $10
Current: $4.87
Upside: +105.34%
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $9.32
Upside: -3.43%
Jul 31, 2026
Reiterated: Buy
Price Target: $3
Current: $0.45
Upside: +566.67%
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $0.8626
Upside: +305.75%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $23.04
Upside: +82.29%
Apr 7, 2026
Reiterated: Buy
Price Target: $5.5 → $3
Current: $2.25
Upside: +33.33%
Aug 13, 2025
Reiterated: Hold
Price Target: $8.5 → $7
Current: $0.00845
Upside: n/a
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $48.68
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.50 → $2.10
Current: $0.11
Upside: n/a